The significance of a set of standardized analytical run in clinical tests with liquid chromatography mass spectrometry

郭玮
DOI: https://doi.org/10.3760/cma.j.cn114452-20200708-00603
2021-01-01
Abstract:Liquid chromatography-mass spectrometry (LC-MS) technology is playing an increasingly important role in clinical precision medicine. Laboratory medicine professionals should pay attention to the universal applicability and particularity of LC-MS technology in quality management. The C62-A guideline issued by the Clinical and Laboratory Standards Institute (CLSI) stipulates that LC-MS must meet the need of special 'additional quality assurance' -analytical run setting, which is worthwhile for reference. We need to establish a specific strategy for a set of standardized analytical run which is suitable for medical laboratories in China, aiming to ensure the accuracy of results of LC-MS tests.
What problem does this paper attempt to address?